文献速递主动脉疾病

术前中性粒细胞-淋巴细胞比值升高预测择期EVAR术后死亡

Elevated neutrophil-lymphocyte ratio predicts mortality following elective endovascular aneurysm repair.
PubMed 文献 · J Vasc Surg · 2020-02-07

单中心回顾性研究纳入108例2010—2018年接受择期EVAR且有术前30天内血常规的患者,以ROC确定NLR阈值4.0。高NLR组1、2、5年死亡率显著更高,多变量分析中NLR与年龄、动脉瘤直径同为死亡独立相关因素。

要点

  • 术前NLR≥4.0的择期EVAR患者远期死亡风险显著升高。
  • 多变量分析中NLR与死亡独立相关(HR 1.19,95%CI 1.12-1.27)。
  • 血常规分类计数廉价易得,可作为EVAR术前预后指标。

核心结论

  • 术前NLR升高的患者,无论其他合并症如何,可能是择期EVAR术后死亡风险增高而此前未被识别的一类人群。
  • 血常规含分类计数是廉价检查,可用作EVAR术后结局的预后指标。

研究设计与样本

  • 单中心2010—2018年择期EVAR患者的回顾性综述(n=373)。
  • 仅纳入术前30天内完成含分类计数血常规的患者,最终108例进入分析。
  • NLR以中性粒细胞绝对计数除以淋巴细胞绝对计数计算,并用ROC曲线确定与死亡关联最强的 cutoff。
  • 连续变量用Wilcoxon非参数符号秩检验,分类变量用Fisher精确检验,生存分析用Kaplan-Meier,Cox回归评估5年随访内与死亡相关的因素。

主要发现

  • NLR≥4.0与死亡相关(P<.0001);高NLR组32例,低NLR组76例。
  • 两组基线特征相似,仅高NLR组年龄更大(77.9 vs 74.4;P=.047)。
  • 平均随访36.4个月,总死亡率为32.4%。
  • 围手术期无差异,但Kaplan-Meier估计高NLR组术后1、2、5年死亡率显著更高(P<.0001)。
  • 死亡者术前NLR均值更高(5.94±5.20;中位数4.75;四分位距3.17-7.83),生存者为2.87±1.61(中位数2.53;四分位距1.97-3.49)(P<.0001)。

关键数值与推荐

  • NLR阈值定为4.0,≥4.0为高NLR组,<4.0为低NLR组。
  • 纳入标准为择期EVAR且术前30天内完成含分类计数的血常规。
  • 多变量模型中NLR的HR为1.19(95%CI 1.12-1.27;P<.0001)。

临床怎么用

  • 择期EVAR术前可读取血常规分类计数计算NLR,将NLR≥4.0者视为死亡风险较高的亚组。
  • 结合年龄与动脉瘤直径等指标共同评估远期生存风险。
  • NLR升高者是否需要更密切随访或干预,尚需进一步研究确定可调控因素。

局限性

  • 单中心回顾性研究,最终仅108例进入分析,样本量有限。
  • NLR阈值4.0由本队列ROC曲线确定,外推需谨慎。
  • 作者指出需进一步研究识别与NLR升高相关的临床、病理或解剖因素及可调控因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The neutrophil-lymphocyte ratio (NLR) is an inexpensive and useful inflammatory marker that incorporates the balance of the innate (neutrophil) and adaptive (lymphocyte) immune responses. Data exist on the association between NLR and mortality in various coronary diseases and in cancer surgery, but there is a paucity of data on the impact of preoperative NLR on vascular surgical outcomes. The aim of this study was to evaluate the relationship between preoperative NLR and elective endovascular aortic aneurysm repair (EVAR) outcome. METHODS: A retrospective review of all patients who underwent elective EVAR at a single institution between 2010 and 2018 was conducted (n = 373). Only patients who had a preoperative complete blood count with differential within 30 days of their operation were included. The NLR was computed by dividing the absolute neutrophil count by the absolute lymphocyte count. A receiver operating characteristic curve was used to determine the optimal cutoff value of NLR with the strongest association with mortality. NLR was dichotomized so that patients with NLR above the threshold were at increased risk of mortality compared with those below it. Continuous variables were analyzed using Wilcoxon nonparametric signed-rank test and categorical variables with the Fisher exact test. A comparison of NLR and mortality was completed using Kaplan-Meier survival analysis. Cox regression analysis was used to evaluate factors associated with mortality through 5-year follow-up. RESULTS: Overall, 108 patients were included in this study. An NLR ≥ 4.0 was found to be associated with mortality (P < .0001). Thirty-two patients composed the High-NLR (NLR ≥ 4.0) group and the remaining 76 patients formed the Low-NLR (NLR < 4.0) group. Baseline characteristics were similar between groups, except that the High-NLR group was older (77.9 vs 74.4; P = .047). At a mean of 36.4 months follow-up, the overall mortality rate was 32.4%. Although there were no differences in the perioperative period, the Kaplan-Meier estimates of mortality were significantly greater in the High-NLR group at 1, 2, and 5 years postoperatively (P < .0001). The mean preoperative NLR of the deceased was higher (5.94 ± 5.20; median, 4.75; interquartile range, 3.17-7.83) than those who survived (2.87 ± 1.61; median, 2.53; interquartile range, 1.97-3.49) (P < .0001). Secondary interventions and sac enlargement rates were similar between groups. On univariable analysis, NLR (hazard ratio [HR], 1.17; 95% confidence interval [CI], 1.10-1.23; P < .0001), age (HR, 1.06; 95% CI, 1.02-1.11; P = .004), and aneurysm diameter (HR, 1.04; 95% CI, 1.01-1.07; P = .003) were associated with mortality. On multivariable analysis, NLR (HR, 1.19; 95% CI, 1.12-1.27; P < .0001), age (HR, 1.06; 95% CI, 1.01-1.11; P = .026), and aneurysm diameter (HR, 1.04; 95% CI, 1.02-1.07; P = .003) were associated with mortality. CONCLUSIONS: Patients with an elevated preoperative NLR, irrespective of other comorbidities, may represent a previously unrecognized subset of patients who are at heightened risk of mortality after elective EVAR. A complete blood count with differential is an inexpensive test that may be used as a prognostic indicator for outcome after EVAR. Further research is warranted to identify clinical, pathological, or anatomical factors associated with an elevated NLR and to determine modifiable factors, which may help improve long-term survival.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. King AH, Schmaier AH, Harth KC, et al. Elevated neutrophil-lymphocyte ratio predicts mortality following elective endovascular aneurysm repair. J Vasc Surg. 2020. PMID: 32037083. doi:10.1016/j.jvs.2019.10.058

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。